This High-Yield ETF Has Increased Payouts 11 Years Straight, and It's Still Undervalued

iShares Core Dividend Growth ETF (DGRO) has delivered consecutive annual dividend increases since its 2014 inception, with a 10-year annual dividend growth rate of ~8.6% versus the S&P 500’s 5.6%; its per-share payouts rose from $0.2577 in 2014 to $1.450642 in 2025. The fund tracks the Morningstar U.S. Dividend Growth Index, requires five-plus years of dividend growth and a payout ratio below 75%, carries a 0.08% expense ratio, a current yield of 2.14%, and a trailing-12-month P/E of ~20.6 (10-year median 18.3) while trading roughly 21% below the S&P 500 on a P/E basis. Top holdings include ExxonMobil, JPMorgan Chase, Johnson & Johnson, Microsoft and Apple, and the portfolio’s overweight to financials and healthcare is highlighted as a potential catalyst should Fed policy keep rates higher and regulatory rollbacks benefit healthcare margins.

Analysis

Market structure: DGRO’s rules concentrate cash-generating, dividend-growing names and overweight financials/healthcare versus tech, creating near-term winners: banks (JPM, XLF) on sticky/higher rates and select healthcare (JNJ, XLV) on deregulation tailwinds. Losers are high-PE, low-yield tech names if capital rotates out of growth into yield; DGRO’s ~21% P/E discount to the S&P and 2.14% yield make it a soak-up target for income reallocation over 3–12 months. Competitive dynamics: sustained higher-for-longer rates would re-price banks upward (net interest margins +100–200bp potential improvement across 6–12 months) while compressing long-duration tech multiples; rebalancing flows into DGRO could increase demand for large-cap dividend payers. Cross-asset: stronger bank earnings and bond yields tighten equity-bond correlation, pressuring long-duration assets, lifting USD on rate expectations and modestly bullish for oil & commodities via growth-linked demand.

Risk assessment: Tail risks include a rate shock that triggers credit losses (bank stress) or a recession causing dividend cuts—low-probability but high-impact over 3–18 months. Hidden dependencies: DGRO’s dividend growth track record depends on corporate buybacks and payout ratios <75%; a systemic earnings shock could force payout resets. Catalysts to monitor: Fed communications and 10y UST yield moves (>+50bp or -50bp in 60 days), Q1/Q2 bank loan-loss provisioning trends, and FDA/regulatory announcements; any reversal could unwind the trade rapidly.

Trade implications: Direct plays—overweight DGRO (2–3% portfolio) and XLF/XLV ETFs for 3–12 month re-rating; pick stocks JPM (long) and JNJ (long) as primary exposures. Pair trades—long XLF (1.5%) vs short XLK (1.0%) to capture relative rerating if rates stay elevated; execute defined-risk 3–6 month call spreads on XLF to lever exposure. Options—buy 3–6 month ATM call spreads on JPM and sell covered calls on JNJ if holding >12 months to boost yield; set tactical exits tied to 10y UST <3.5% or Fed signaling ≥2 cuts.

Contrarian angles: Consensus underestimates banks’ ability to widen margins without immediate credit deterioration; opportunity is underdone if 10y stays >3.75% for next 6–12 months—banks may rerate +15–25% relative to growth. Conversely, deregulation hopes for healthcare are priced into some large caps; regulatory rollback momentum can stall, creating asymmetric risk if clinical/regulatory setbacks occur. Historical parallels: 2016–2019 rate-rerate in banks shows profits lag but re-rating can be durable; unintended consequence—short-term dividend stability may mask rising payout risk if buybacks fall and EPS contracts.

Key Decisions for Investors

• Establish a 2–3% portfolio long position in iShares Core Dividend Growth ETF (DGRO) within 30 days to capture 2.14% yield and durable dividend growth; plan a 12–18 month hold and trim if DGRO’s trailing P/E exceeds S&P P/E by >5 points or 10y UST yield drops below 3.50%.
• Initiate a relative-value pair: long XLF (1.5% portfolio) and short XLK (1.0%) for a 3–9 month trade to capture financials rerating if the Fed signals fewer than two cuts in the next 12 months; use a 3–6 month call spread on XLF (buy ATM, sell +5% strike) to concentrate upside with defined risk.
• Buy 1–1.5% long positions in JPM and JNJ: for JPM, use a 3–6 month call spread to express margin upside (defined-risk); for JNJ, buy and sell 12-month covered calls to enhance yield (target covered-call premium ≥1.5% annualized).
• Reduce high-PE tech exposure (e.g., NVDA, oversized growth positions) by 25–40% if current weight >5%, redeploy proceeds into DGRO/XLF/XLV; unwind reallocations within 30 days if 10y UST falls >50bp or Fed signals ≥2 cuts, or if S&P outperforms DGRO by >5% in 60 days.